報告摘要

The global Thalomid market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032. The North America market for Thalomid is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032. The Europe market for Thalomid is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. The Asia Pacific market for Thalomid is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global manufacturers of Thalomid include Celgene. among others. In 2025, the top three vendors together accounted for approximately % of global revenue. Report Scope This report quantifies the global Thalomid market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032. It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems. Key Companies & Market Share Insights This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking. Thalomid Market by Company Celgene Thalomid Segment by Type 50mg 100mg 200mg Thalomid Segment by Application Retail Pharmacy Hospital Pharmacy Other Thalomid Segment by Region North America United States Canada Europe Germany France U.K. Italy Netherlands Nordic Countries Asia-Pacific China Japan South Korea India Australia China Taiwan Southeast Asia South America Mexico Brazil Argentina Colombia Middle East & Africa Turkey Saudi Arabia UAE Key Drivers & Barriers High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects. Reasons to Buy This Report 1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Thalomid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market. 2. This report will help stakeholders to understand the global industry status and trends of Thalomid and provides them with information on key market drivers, restraints, challenges, and opportunities. 3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition. 4. This report stays updated with novel technology integration, features, and the latest developments in the market 5. This report helps stakeholders to gain insights into which regions to target globally 6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Thalomid. 7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution. Chapter Outline Chapter 1: Research objectives, research methods, data sources, data cross-validation; Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 3: Detailed analysis of Thalomid manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc. Chapter 5: Production/output, value of Thalomid by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years. Chapter 6: Consumption of Thalomid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world. Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 11: The main points and conclusions of the report.

目錄 Table of Contents

1 Preface 1.1 Scope of Report 1.2 Reasons for Doing This Study 1.3 Research Methodology 1.4 Research Process 1.5 Data Source 1.5.1 Secondary Sources 1.5.2 Primary Sources 2 Market Overview 2.1 Product Definition 2.2 Global Market Growth Prospects 2.2.1 Global Thalomid Market Size (2021-2032) 2.2.2 Global Thalomid Sales (2021-2032) 2.2.3 Global Thalomid Market Average Price (2021-2032) 2.3 Thalomid by Type 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) 2.3.2 50mg 2.3.3 100mg 2.3.4 200mg 2.4 Thalomid by Application 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) 2.4.2 Retail Pharmacy 2.4.3 Hospital Pharmacy 2.4.4 Other 3 Market Competitive Landscape by Manufacturers 3.1 Global Thalomid Market Competitive Situation by Manufacturers (2021 Versus 2025) 3.2 Global Thalomid Sales (K Units) of Manufacturers (2021-2026) 3.3 Global Thalomid Revenue of Manufacturers (2021-2026) 3.4 Global Thalomid Average Price by Manufacturers (2021-2026) 3.5 Global Thalomid Industry Ranking, 2024 VS 2025 VS 2026 3.6 Global Manufacturers of Thalomid, Manufacturing Sites & Headquarters 3.7 Global Manufacturers of Thalomid, Product Type & Application 3.8 Global Manufacturers of Thalomid, Established Date 3.9 Global Thalomid Market CR5 and HHI 3.10 Global Manufacturers Mergers & Acquisition 4 Manufacturers Profiled 4.1 Celgene 4.1.1 Celgene Company Information 4.1.2 Celgene Business Overview 4.1.3 Celgene Thalomid Sales, Revenue and Gross Margin (2021-2026) 4.1.4 Celgene Thalomid Product Portfolio 4.1.5 Celgene Recent Developments 5 Global Thalomid Market Scenario by Region 5.1 Global Thalomid Market Size by Region: 2021 VS 2025 VS 2032 5.2 Global Thalomid Sales by Region: 2021-2032 5.2.1 Global Thalomid Sales by Region: 2021-2026 5.2.2 Global Thalomid Sales by Region: 2027-2032 5.3 Global Thalomid Revenue by Region: 2021-2032 5.3.1 Global Thalomid Revenue by Region: 2021-2026 5.3.2 Global Thalomid Revenue by Region: 2027-2032 5.4 North America Thalomid Market Facts & Figures by Country 5.4.1 North America Thalomid Market Size by Country: 2021 VS 2025 VS 2032 5.4.2 North America Thalomid Sales by Country (2021-2032) 5.4.3 North America Thalomid Revenue by Country (2021-2032) 5.4.4 United States 5.4.5 Canada 5.5 Europe Thalomid Market Facts & Figures by Country 5.5.1 Europe Thalomid Market Size by Country: 2021 VS 2025 VS 2032 5.5.2 Europe Thalomid Sales by Country (2021-2032) 5.5.3 Europe Thalomid Revenue by Country (2021-2032) 5.5.4 Germany 5.5.5 France 5.5.6 U.K. 5.5.7 Italy 5.5.8 Netherlands 5.5.9 Nordic Countries 5.6 Asia Pacific Thalomid Market Facts & Figures by Country 5.6.1 Asia Pacific Thalomid Market Size by Country: 2021 VS 2025 VS 2032 5.6.2 Asia Pacific Thalomid Sales by Country (2021-2032) 5.6.3 Asia Pacific Thalomid Revenue by Country (2021-2032) 5.6.4 China 5.6.5 Japan 5.6.6 South Korea 5.6.7 India 5.6.8 Australia 5.6.9 China Taiwan 5.6.10 Southeast Asia 5.7 South America Thalomid Market Facts & Figures by Country 5.7.1 South America Thalomid Market Size by Country: 2021 VS 2025 VS 2032 5.7.2 South America Thalomid Sales by Country (2021-2032) 5.7.3 South America Thalomid Revenue by Country (2021-2032) 5.7.4 Mexico 5.7.5 Brazil 5.7.6 Argentina 5.7.7 Colombia 5.8 Middle East and Africa Thalomid Market Facts & Figures by Country 5.8.1 Middle East and Africa Thalomid Market Size by Country: 2021 VS 2025 VS 2032 5.8.2 Middle East and Africa Thalomid Sales by Country (2021-2032) 5.8.3 Middle East and Africa Thalomid Revenue by Country (2021-2032) 5.8.4 Turkey 5.8.5 Saudi Arabia 5.8.6 UAE 6 Segment by Type 6.1 Global Thalomid Sales by Type (2021-2032) 6.1.1 Global Thalomid Sales by Type (2021-2032) & (K Units) 6.1.2 Global Thalomid Sales Market Share by Type (2021-2032) 6.2 Global Thalomid Revenue by Type (2021-2032) 6.2.1 Global Thalomid Sales by Type (2021-2032) & (US$ Million) 6.2.2 Global Thalomid Revenue Market Share by Type (2021-2032) 6.3 Global Thalomid Price by Type (2021-2032) 7 Segment by Application 7.1 Global Thalomid Sales by Application (2021-2032) 7.1.1 Global Thalomid Sales by Application (2021-2032) & (K Units) 7.1.2 Global Thalomid Sales Market Share by Application (2021-2032) 7.2 Global Thalomid Revenue by Application (2021-2032) 7.2.1 Global Thalomid Sales by Application (2021-2032) & (US$ Million) 7.2.2 Global Thalomid Revenue Market Share by Application (2021-2032) 7.3 Global Thalomid Price by Application (2021-2032) 8 Value Chain and Sales Channels Analysis of the Market 8.1 Thalomid Value Chain Analysis 8.1.1 Thalomid Key Raw Materials 8.1.2 Raw Materials Key Suppliers 8.1.3 Thalomid Production Mode & Process 8.2 Thalomid Sales Channels Analysis 8.2.1 Direct Comparison with Distribution Share 8.2.2 Thalomid Distributors 8.2.3 Thalomid Customers 9 Global Thalomid Analyzing Market Dynamics 9.1 Thalomid Industry Trends 9.2 Thalomid Industry Drivers 9.3 Thalomid Industry Opportunities and Challenges 9.4 Thalomid Industry Restraints 10 Report Conclusion 11 Disclaimer

圖表清單 List of Tables & Figures

List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Thalomid Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Thalomid Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Thalomid Sales Market Share by Manufacturers (2021-2026) Table 8. Global Thalomid Revenue of Manufacturers (2021-2026) Table 9. Global Thalomid Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Thalomid Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Thalomid Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Thalomid, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Thalomid, Product Type & Application Table 14. Global Thalomid Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Thalomid by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Celgene Company Information Table 19. Celgene Business Overview Table 20. Celgene Thalomid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Celgene Thalomid Product Portfolio Table 22. Celgene Recent Developments Table 23. Global Thalomid Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 24. Global Thalomid Sales by Region (2021-2026) & (K Units) Table 25. Global Thalomid Sales Market Share by Region (2021-2026) Table 26. Global Thalomid Sales by Region (2027-2032) & (K Units) Table 27. Global Thalomid Sales Market Share by Region (2027-2032) Table 28. Global Thalomid Revenue by Region (2021-2026) & (US$ Million) Table 29. Global Thalomid Revenue Market Share by Region (2021-2026) Table 30. Global Thalomid Revenue by Region (2027-2032) & (US$ Million) Table 31. Global Thalomid Revenue Market Share by Region (2027-2032) Table 32. North America Thalomid Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 33. North America Thalomid Sales by Country (2021-2026) & (K Units) Table 34. North America Thalomid Sales by Country (2027-2032) & (K Units) Table 35. North America Thalomid Revenue by Country (2021-2026) & (US$ Million) Table 36. North America Thalomid Revenue by Country (2027-2032) & (US$ Million) Table 37. Europe Thalomid Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Europe Thalomid Sales by Country (2021-2026) & (K Units) Table 39. Europe Thalomid Sales by Country (2027-2032) & (K Units) Table 40. Europe Thalomid Revenue by Country (2021-2026) & (US$ Million) Table 41. Europe Thalomid Revenue by Country (2027-2032) & (US$ Million) Table 42. Asia Pacific Thalomid Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Asia Pacific Thalomid Sales by Country (2021-2026) & (K Units) Table 44. Asia Pacific Thalomid Sales by Country (2027-2032) & (K Units) Table 45. Asia Pacific Thalomid Revenue by Country (2021-2026) & (US$ Million) Table 46. Asia Pacific Thalomid Revenue by Country (2027-2032) & (US$ Million) Table 47. South America Thalomid Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 48. South America Thalomid Sales by Country (2021-2026) & (K Units) Table 49. South America Thalomid Sales by Country (2027-2032) & (K Units) Table 50. South America Thalomid Revenue by Country (2021-2026) & (US$ Million) Table 51. South America Thalomid Revenue by Country (2027-2032) & (US$ Million) Table 52. Middle East and Africa Thalomid Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Middle East and Africa Thalomid Sales by Country (2021-2026) & (K Units) Table 54. Middle East and Africa Thalomid Sales by Country (2027-2032) & (K Units) Table 55. Middle East and Africa Thalomid Revenue by Country (2021-2026) & (US$ Million) Table 56. Middle East and Africa Thalomid Revenue by Country (2027-2032) & (US$ Million) Table 57. Global Thalomid Sales by Type (2021-2026) & (K Units) Table 58. Global Thalomid Sales by Type (2027-2032) & (K Units) Table 59. Global Thalomid Sales Market Share by Type (2021-2026) Table 60. Global Thalomid Sales Market Share by Type (2027-2032) Table 61. Global Thalomid Revenue by Type (2021-2026) & (US$ Million) Table 62. Global Thalomid Revenue by Type (2027-2032) & (US$ Million) Table 63. Global Thalomid Revenue Market Share by Type (2021-2026) Table 64. Global Thalomid Revenue Market Share by Type (2027-2032) Table 65. Global Thalomid Price by Type (2021-2026) & (US$/Unit) Table 66. Global Thalomid Price by Type (2027-2032) & (US$/Unit) Table 67. Global Thalomid Sales by Application (2021-2026) & (K Units) Table 68. Global Thalomid Sales by Application (2027-2032) & (K Units) Table 69. Global Thalomid Sales Market Share by Application (2021-2026) Table 70. Global Thalomid Sales Market Share by Application (2027-2032) Table 71. Global Thalomid Revenue by Application (2021-2026) & (US$ Million) Table 72. Global Thalomid Revenue by Application (2027-2032) & (US$ Million) Table 73. Global Thalomid Revenue Market Share by Application (2021-2026) Table 74. Global Thalomid Revenue Market Share by Application (2027-2032) Table 75. Global Thalomid Price by Application (2021-2026) & (US$/Unit) Table 76. Global Thalomid Price by Application (2027-2032) & (US$/Unit) Table 77. Key Raw Materials Table 78. Raw Materials Key Suppliers Table 79. Thalomid Distributors List Table 80. Thalomid Customers List Table 81. Thalomid Industry Trends Table 82. Thalomid Industry Drivers Table 83. Thalomid Industry Restraints Table 84. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Thalomid Product Image Figure 5. Global Thalomid Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Thalomid Market Size (2021-2032) & (US$ Million) Figure 7. Global Thalomid Sales (2021-2032) & (K Units) Figure 8. Global Thalomid Average Price (US$/Unit) & (2021-2032) Figure 9. 50mg Product Image Figure 10. 100mg Product Image Figure 11. 200mg Product Image Figure 12. Retail Pharmacy Product Image Figure 13. Hospital Pharmacy Product Image Figure 14. Other Product Image Figure 15. Global Thalomid Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Thalomid, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Thalomid Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Thalomid Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Thalomid Sales by Region in 2025 Figure 21. Global Thalomid Revenue by Region in 2025 Figure 22. North America Thalomid Market Size by Country in 2025 Figure 23. North America Thalomid Sales Market Share by Country (2021-2032) Figure 24. North America Thalomid Revenue Market Share by Country (2021-2032) Figure 25. United States Thalomid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Thalomid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Thalomid Market Size by Country in 2025 Figure 28. Europe Thalomid Sales Market Share by Country (2021-2032) Figure 29. Europe Thalomid Revenue Market Share by Country (2021-2032) Figure 30. Germany Thalomid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Thalomid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Thalomid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Thalomid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Netherlands Thalomid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Nordic Countries Thalomid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Asia Pacific Thalomid Market Size by Country in 2025 Figure 37. Asia Pacific Thalomid Sales Market Share by Country (2021-2032) Figure 38. Asia Pacific Thalomid Revenue Market Share by Country (2021-2032) Figure 39. China Thalomid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Japan Thalomid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. South Korea Thalomid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. India Thalomid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Australia Thalomid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. China Taiwan Thalomid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia Thalomid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Southeast Asia Thalomid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South America Thalomid Market Size by Country in 2025 Figure 48. South America Thalomid Sales Market Share by Country (2021-2032) Figure 49. South America Thalomid Revenue Market Share by Country (2021-2032) Figure 50. Mexico Thalomid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Brazil Thalomid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Argentina Thalomid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Colombia Thalomid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Middle East and Africa Thalomid Market Size by Country in 2025 Figure 55. Middle East and Africa Thalomid Sales Market Share by Country (2021-2032) Figure 56. Middle East and Africa Thalomid Revenue Market Share by Country (2021-2032) Figure 57. Turkey Thalomid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Thalomid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. UAE Thalomid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Global Thalomid Sales Market Share by Type (2021-2032) Figure 61. Global Thalomid Revenue Market Share by Type (2021-2032) Figure 62. Global Thalomid Price (US$/Unit) by Type (2021-2032) Figure 63. Global Thalomid Sales Market Share by Application (2021-2032) Figure 64. Global Thalomid Revenue Market Share by Application (2021-2032) Figure 65. Global Thalomid Price (US$/Unit) by Application (2021-2032) Figure 66. Thalomid Value Chain Figure 67. Thalomid Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Thalomid Industry Opportunities and Challenges

Single User	$2,950 USD
Multi User	$4,430 USD
Enterprise	$5,900 USD

Thalomid Industry Research Report 2026

授權報價

報告摘要

提及公司